Families Prefer Hospice Over Hospital for Dying Relatives

This article originally appeared here.
Share this content:
Families Prefer Hospice Over Hospital for Dying Relatives
Families Prefer Hospice Over Hospital for Dying Relatives

WEDNESDAY, Jan. 20, 2016 (HealthDay News) -- Families of patients dying of cancer believe their loved one had better care and quality of life when they died in a hospice rather than in a hospital's intensive care unit, according to research published in the Jan. 19 issue of the Journal of the American Medical Association, a theme issue on death, dying, and end of life.

Alexi Wright, M.D., M.P.H., an associate professor of medicine at Harvard Medical School in Boston, and colleagues collected data on 1,146 cancer patients. The investigators used data from interviews with family members of Medicare patients with advanced lung or colorectal cancer from a study of patients who died by the end of 2011.

Relatives reported a better end-of-life experience more often when their loved one received hospice care for more than three days (58.8 percent) than those who received hospice care for three or fewer days (43.1 percent). Moreover, only 45.0 percent of families reported excellent care when the patient was admitted to a hospital intensive care unit (ICU) within 30 days of dying. The researchers also found that only 42.2 percent of families of patients who died in the hospital said their loved one had excellent end-of-life care, compared with 57.4 percent of families whose loved ones died at home or in a hospice. In addition, family members of patients who did not receive hospice care or received three or fewer days of hospice care were less likely to report the patient died in their preferred location (40.0 percent) than those who received hospice care for more than three days (72.8 percent).

"Efforts to increase earlier hospice enrollment and avoid ICU admissions and hospital deaths are important areas to focus on to improve the quality of end-of-life care," Wright told HealthDay.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »